AI | pharmaphorum

AI

Digital

Tackling ongoing staffing burnout rates through AI-enabled p...

The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows.

Sales & Marketing

Automating - and optimising - HCP engagement to maximise com...

Life sciences marketing has rapidly evolved to mirror that of consumer retail.

News

Sanofi, CytoReason expand AI deal into IBD

Tech company CytoReason has announced it has signed a multi-year, multimillion dollar deal with Sanofi to deliver artificial intelligence (AI) for drug discovery and development in the fiel

Digital

2023 predictions and challenges in the healthcare business

With a new year comes an opportunity for professionals in the healthcare industry to evaluate goals and initiatives for 2023.

Digital

The importance of AI literacy in life sciences

The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.

Patients

The rise of prescription drug abuse and drug diversion

As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased.

Tackling ongoing staffing burnout rates through AI-enabled p...

Automating - and optimising - HCP engagement to maximise com...

Sanofi, CytoReason expand AI deal into IBD

2023 predictions and challenges in the healthcare business

The importance of AI literacy in life sciences

The rise of prescription drug abuse and drug diversion

AZ's gMG drug Klygefa nears EU approval

Discover a new era of healthcare panel engagement: Grounded ...

AI

Editor's Picks